Attention-Deficit Hyperactivity Disorder (ADHD)
3 Hallmark symptoms:
inattention
hyperactivity
impulsivity
Age of onset is usually before 12
Risk of comorbid psychiatric disorders with ADHD
Symptoms of ADHD must persist for at least 6 months to be considered diagnostic
Screen via the following for cardiovascular risk factors before initiating stimulants:
blood pressure, heart rate, height/weight, re-assess at f/u
only ECG in patients with concurrent cardiac abnormalities or those with a family hx of cardiac disease or sudden death
Therapy
Nonpharmacological
parent/teacher training first-line in pre-school aged children
Options include:
behaviour management, CBT, parent training, organizational skill training, etc.
less effective than stimulants, but combined nonpharm/pharm therapy observed to be more effective than either alone
Exercise also found to improve core ADHD symptoms, reduce anxiety, and improve cognitive function
insufficient data exists to say whether specific diets affed ADHD signs/symptoms
Pharmacological
methylphenidate only considered in preschoolers if they have moderate to severe ADHD and do not respond to behavioural therapy. This is along as the benefit outweighs the harm
Stimulants
long-acting stimulants considered first-line
Efficacy and safety differences between stimulants are minimal
Limited evidence shows preference for amphetamines as first line for adults, and methylphenidate for children
Immediate- and intermediate-acting stimulants are recommended for use when the patient requires more flexible dosing and minimal hours/day of medication or as add-on therapy to an extended-release formulation.
Benefit is typically seen in the first week of therapy-
A full trial is 3-4 weeks for stimulants, with a continuation for 6-12 months if response is adequate with little to no adverse effects
Stimulant contraindications:
history of hypersensitivity to sympathomimetic amines
symptomatic CVD
uncontrolled hyperthyroidism
Hx of drug abuse
concurrent use with an MAOI
What CNS stimulant is not typically used in ADHD due to reduced efficacy?
Modafinil
Long-Acting Stimulants
Drugs | Duration of Action | Safety | Interactions | Notes |
Lisdexamphetamine (Vyvanse) | 13 to 14 hours | |||
Methylphenidate CR (Biphentin) | 10-12 hours | |||
Mixed salts amphetamine (Adderall XR) | 10-12 hrs |
Intermediate-Acting Stimulants
Drugs | Duration of Action | Safety | Interactions | Notes |
Methylphenidate SR (Ritalin) | 3-8 hrs | |||
Dextroamphetamine SR (Dexedrine) | 6-8 hrs |
Immediate-Acting Stimulants
Drugs | Duration of Action | Safety | Interactions | Notes |
Dextroamphetamine IR | 3-5 hrs | Common: |
| |
Stimulant OD symptoms: glassy eyes, insomnia, hyperactivity